Governance ResMed, Inc.

RMD

US7611521078

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 02:30:02 06/12/2025 am IST			5-day change	1st Jan Change
256.55 ^USD	+2.00%		+0.28%	+12.18%

05/12	Resmed Insider Sold Shares Worth $502,940, According to a Recent SEC Filing	MT
02/12	LivaNova PLC Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea, Effective December 1, 2025	CI

Executive Committee: ResMed, Inc.

Manager

Positions heldSince

Mick Farrell

52 year

Chief Executive Officer

01/03/2013

Sallilyn Schwartz

Investor Relations Contact

21/04/2025

Jim Ellis

Compliance Officer

01/01/2018

Yvonne-Katrin Pucknat

Sales & Marketing

09/11/2023

Michael Rider

General Counsel	01/07/2023
Corporate Secretary	01/07/2023

Brett Sandercock

58 year

Director of Finance/CFO

01/01/2006

Vered Keisar

Human Resources Officer

01/03/2021

Carlos Nunez

Chief Tech/Sci/R&D Officer

03/01/2017

Composition of the Board of Directors: ResMed, Inc.

Director

CommitteesSince

Mick Farrell

52 year

Compensation Committee Chair

12/12/2014

Karen Drexler

65 year

Audit Committee	08/11/2021
Compensation Committee Chair	08/11/2021
Governance Committee	17/11/2017
Nominating Committee	17/11/2017
Compensation Committee
Governance Committee Chair	08/01/2021
Nominating Committee Chair	08/11/2021

Peter Farrell

82 year

Audit Committee	31/05/2018
Executive Committee	31/05/2018
Compensation Committee	31/05/2018
Governance Committee Chair	31/05/2018
Nominating Committee Chair	31/05/2018

Carol Burt

67 year

Audit Committee	01/10/2019
Governance Committee	01/11/2013
Nominating Committee Chair	01/11/2013
Audit Committee Chair
Compensation Committee Chair

Ron Taylor

77 year

Audit Committee	01/01/2005
Governance Committee	13/03/2015
Nominating Committee	13/03/2015

Harjit Gill

60 year

Audit Committee	15/11/2018
Compensation Committee	15/11/2018

Nicole Mowad-Nassar

54 year

Compensation Committee

15/08/2025

Jan De Witte

60 year

Audit Committee

16/05/2019

John Hernandez

58 year

Audit Committee

Desney Tan

49 year

Compensation Committee

18/11/2021

Christopher DelOrefice

53 year

Audit Committee Chair

15/08/2024

Latest Appointments: ResMed, Inc.

02/12	LivaNova PLC Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea, Effective December 1, 2025	CI
26/11	ResMed Inc. Announces Not Seek Re-Election of Richard Sulpizio to the Board of Directors, Effective November 19, 2025	CI
16/10	NZX Announces Executive Changes	CI
14/10	PolyNovo Limited Announces Appointment of Robert Douglas to the Board of Directors	CI
19/08	Resmed announces election of Nicole Mowad-Nassar to board, upcoming retirement of Rich Sulpizio	RE
19/08	ResMed Inc. Announces Board Changes	CI
01/08	Resmed Inc. Announces Resignation of Bobby Ghoshal as Chief Commercial Officer, Residential Care Software Business, Effective August 1, 2025	CI

More news

Former Officers and Directors: ResMed, Inc.

Insider

Positions held

SinceUntil

Rich Sulpizio

Director/Board Member	25/08/2005	19/11/2025
Independent Dir/Board Member	25/08/2005	19/11/2025

Bobby Ghoshal

Chief Tech/Sci/R&D Officer	02/04/2018	01/02/2022
Corporate Officer/Principal	01/02/2022	01/08/2025

Rob Douglas

Chief Operating Officer	02/09/2011	09/11/2023
Corporate Officer/Principal	01/01/2002	02/09/2011
President	01/03/2013	09/11/2023
Sales & Marketing	01/01/2001	01/01/2002

Urvashi Tyagi

Chief Tech/Sci/R&D Officer

01/02/2022

09/11/2023

Jayme Rubenstein

Public Communications Contact

01/07/2023

David Pendarvis

Chief Administrative Officer	01/05/2011	30/06/2023
General Counsel	01/09/2002	30/06/2023
Corporate Secretary	01/02/2003	30/06/2023

Anne Crotteau

Public Communications Contact

01/01/2018

01/08/2022

Mehul Joshi

Corporate Officer/Principal

01/05/2011

01/07/2022

James Hollingshead

Corporate Officer/Principal

01/03/2010

05/05/2022

Rajwant Singh Sodhi

Chief Tech/Sci/R&D Officer	01/07/2017	02/04/2018
Corporate Officer/Principal	02/04/2018	01/09/2021

Jack Wareham

Director/Board Member	01/01/2005	21/11/2019
Independent Dir/Board Member	01/01/2005	21/11/2019

Geoff Neilson

Corporate Officer/Principal

28/06/2011

01/12/2018

Amy Wakeham

Investor Relations Contact	01/06/2018	-
Public Communications Contact	01/06/2018	01/11/2023

Gary Pace

Director/Board Member	01/01/1994	01/01/2018
Independent Dir/Board Member	01/01/1994	01/01/2018

Chris Roberts

Director/Board Member	01/01/1992	17/11/2017
President	01/01/1992	17/11/2017

Frank Lacagnina

Chief Tech/Sci/R&D Officer

01/09/2010

01/11/2017

Anne Reiser

Corporate Officer/Principal

01/01/2006

01/09/2017

Andrew Price

Corporate Officer/Principal

01/07/2017

Nupur Bhushan

Human Resources Officer

01/07/2017

Michael Quinn Anthony

Director/Board Member

01/07/1992

01/11/2013

Richie McHale

Human Resources Officer

01/11/2013

Stein Jacobsen

Corporate Officer/Principal

01/01/2009

31/03/2012

Karen Borg

Corporate Officer/Principal

01/01/2012

Michael Zill

Chief Tech/Sci/R&D Officer

01/06/2006

01/12/2011

Jean-Claude Kyrillos

President

01/01/2008

01/08/2011

Kieran Gallahue

Director/Board Member	01/01/2008	28/01/2011
Chief Executive Officer	01/01/2008	28/01/2011
Corporate Officer/Principal	01/01/2003	01/09/2004
President	01/09/2004	28/01/2011

Donagh McCarthy

Director/Board Member

01/11/1994

30/05/2008

Keith M. Serzen

Corporate Officer/Principal

01/09/2003

09/04/2008

Lasse Beijer

Corporate Officer/Principal

01/06/2007

Adrian M. Smith

Corporate Officer/Principal

01/02/1995

31/05/2007

Todd Pinkowski

Corporate Officer/Principal

01/01/1998

01/01/2007

Harold Picken

Corporate Officer/Principal

01/01/2006

Christopher A. Bartlett

Director/Board Member

01/10/2000

25/08/2005

Connie L. Garrett

Human Resources Officer

01/01/1999

01/01/2004

Kristie Burns

Public Communications Contact	01/02/2016	-
Sales & Marketing	01/12/2003	01/02/2016

Wai Keei Sum

Corporate Officer/Principal

01/01/2003

Paul Eisen

Corporate Officer/Principal

01/01/2002

Donald Darkin

Corporate Officer/Principal

28/09/2010

Theresa Lowry

Human Resources Officer

Alison Graves

Public Communications Contact

Agnes Lee

Investor Relations Contact	-	-
Public Communications Contact	-	-

Louis Allen Simpsoni

Director/Board Member

01/05/2002

25/01/2005

Steve Moore

Sales & Marketing

Ronald F. Richard

Sales & Marketing

Klaus H. Shindhelm

Chief Operating Officer

Walter Flicker

Corporate Officer/Principal

Curt Kenyon

Director/Board Member

Hillary Theakston

Public Communications Contact

Nicholas J. Kuhn

Corporate Officer/Principal

Michael S. Hirshorn

Director/Board Member

Jonathan C. Wright

Sales & Marketing

Stefan Elterich

Sales & Marketing

Anthony Ujhazy

Corporate Officer/Principal

Matthew Borer

Public Communications Contact

28/10/2009

Constance C. Bienfait

Investor Relations Contact	-	-
Public Communications Contact	-	-

Birgit Fibian

Sales & Marketing

Jon Brockman

Corporate Officer/Principal

Zabrina Doerck

Public Communications Contact

Leo Toole

Director of Finance/CFO

Age distribution of managers

Parity Men Women

Male	18
Female	9

Of which Executive Committee

Male	5
Female	3

Of which Directors

Male	7
Female	4

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.

Employees

10,600

Sector

Advanced Medical Equipment & Technology

Calendar

22/01 - Q2 2026 Earnings Release (Projected)

More about the company